These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9721436)

  • 1. Preclinical evaluation of a new immunosuppressive agent, FTY720.
    Troncoso P; Kahan BD
    Clin Biochem; 1998 Jul; 31(5):369-73. PubMed ID: 9721436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 3. FTY720: A new kid on the block for transplant immunosuppression.
    Aki FT; Kahan BD
    Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
    Kahan BD
    Ther Drug Monit; 2002 Feb; 24(1):47-52. PubMed ID: 11805722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720: a new dimension in transplantation.
    Kahan BD
    Transplant Proc; 2001; 33(7-8):3081-3. PubMed ID: 11750324
    [No Abstract]   [Full Text] [Related]  

  • 6. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 7. FTY720: a most promising immunosuppressant modulating immune cell functions.
    Zhang Z; Schluesener HJ
    Mini Rev Med Chem; 2007 Aug; 7(8):845-50. PubMed ID: 17692046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine.
    Mansoor M; Melendez AJ
    Rev Recent Clin Trials; 2008 Jan; 3(1):62-9. PubMed ID: 18474015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation.
    Brinkmann V; Pinschewer D; Chiba K; Feng L
    Trends Pharmacol Sci; 2000 Feb; 21(2):49-52. PubMed ID: 10664606
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus and FTY720: new approaches to transplant immunosuppression.
    Kahan BD
    Transplant Proc; 2002 Nov; 34(7):2520-2. PubMed ID: 12431509
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
    Paugh SW; Payne SG; Barbour SE; Milstien S; Spiegel S
    FEBS Lett; 2003 Nov; 554(1-2):189-93. PubMed ID: 14596938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.
    Chen S; Bacon KB; Garcia G; Liao R; Pan ZK; Sullivan SK; Nakano H; Matsuzawa A; Brinkmann V; Feng L
    Transplant Proc; 2001; 33(7-8):3057-63. PubMed ID: 11750317
    [No Abstract]   [Full Text] [Related]  

  • 13. FTY720: mechanisms of action and its effect on organ transplantation (review).
    Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
    Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
    Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
    Yang D; Sun YY; Bhaumik SK; Li Y; Baumann JM; Lin X; Zhang Y; Lin SH; Dunn RS; Liu CY; Shie FS; Lee YH; Wills-Karp M; Chougnet CA; Kallapur SG; Lewkowich IP; Lindquist DM; Murali-Krishna K; Kuan CY
    J Neurosci; 2014 Dec; 34(49):16467-81. PubMed ID: 25471584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
    Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
    Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720: mechanism of action and potential benefit in organ transplantation.
    Brinkmann V
    Yonsei Med J; 2004 Dec; 45(6):991-7. PubMed ID: 15627289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
    Miyamoto T; Matsumori A; Hwang MW; Nishio R; Ito H; Sasayama S
    J Am Coll Cardiol; 2001 May; 37(6):1713-8. PubMed ID: 11345389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.